Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04917055 · ClinicalTrials.gov registry record · Phase 4
iPACK Block With Dexamethasone For Total Knee Replacement
A Phase 4 study, sponsored by University of California, San Diego.
- Terminated
- Registry status
- Phase 4
- Development phase
- 14
- Enrollment target
NCT04917055: Clinical Trial Phase 4 study, sponsored by University of California, San Diego.
NCT04917055 is a Phase 4 study that was terminated before completion, run by University of California, San Diego. The registered enrollment target is 14 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04917055, a Phase 4 study, was terminated before completion, sponsored by University of California, San Diego.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 14 participants
- Enrollment target
Study Summary
Comparing the pain control outcomes for patients undergoing total knee arthroplasty (TKA) with either: 1) adductor canal single shot injection plus placebo iPACK injection or 2) adductor canal single shot injection plus bupivacaine and dexamethasone iPACK injection. There are two surgical approaches for TKA 1) open 2) ROSA robotic assisted. Both follow the same pain management pathway. We plan to enroll patient undergoing either surgical procedure.
Primary Outcome
Average Opioid Use
Interventions
- DRUG Saline
- DRUG ropivacaine 0.25% with epinephrine and 6mg dexamethasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2021-06-07 |
| Est. Completion | 2022-06-07 |
| Phase | Phase 4 |
Why NCT04917055 stopped before completion
NCT04917055 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT04917055 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04917055 about?
NCT04917055 is a clinical study titled "iPACK Block With Dexamethasone For Total Knee Replacement". Comparing the pain control outcomes for patients undergoing total knee arthroplasty (TKA) with either: 1) adductor canal single shot injection plus placebo iPACK injection or 2) adductor canal single shot injection plus bupivacaine and dexamethasone iPACK injection. There are two surgical approache...
What is the current status of trial NCT04917055?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 14 participants. The study started on 2021-06-07. Estimated completion is 2022-06-07.
What interventions are being tested in trial NCT04917055?
The interventions under investigation include: Saline (DRUG), ropivacaine 0.25% with epinephrine and 6mg dexamethasone (DRUG).
Who is sponsoring clinical trial NCT04917055?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04917055's enrollment target sits among peer trials
14 1901st of 2000 higher than 91 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy